Prognostic value of elevated biomarkers in diabetic and non-diabetic patients admitted for acute coronary syndromes

Heart

Volumn 91, Issue 3, 2005, Pages 388-390

  Fazel, R ^a   Fang, J ^a   Kline Rogers, I ^a   Smith, D E ^a   Eagle, K A ^a   Mukherjee, Debabrata ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEART ENZYME; ORAL ANTIDIABETIC AGENT; CREATINE KINASE; TROPONIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIET; FEMALE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART REINFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; TRANSIENT ISCHEMIC ATTACK; BLOOD; DIABETIC ANGIOPATHY; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; SYNDROME; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CREATINE KINASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; SYNDROME; TROPONIN;

EID: 14244260766     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.032797     Document Type: Article

References (6)

1. Yudkin JS, Oswald GA. Determinants of hospital admission and case fatality in diabetic-patients with myocardial-infarction. Diabetes Care 1988;11:351-8.
2. Kouvaras G, Cokkinos D, Spyropoulou M. Increased mortality of diabetics after acute myocardial-infarction attributed to diffusely impaired left-ventricular performance as assessed by echocardiography. Jpn Heart J 1988;29:1-9.
3. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
4. James S, Armstrong P, Califf R, et al. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am J Med 2003;115:178-84:
5. Newby LK, Goldmann BU, Ohman EM. Troponin: an important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2003;41:31-6S.
6. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002;359:2140-4.